4JVE |
Co-crystal structure of MDM2 with inhibitor (2R,3E)-2-[(2S,3R,6S)-2,3-bis(4-chlorophenyl)-6-(4-fluorobenzyl)-5-oxomorpholin-4-yl]pent-3-enoic acid |
date |
2013-03-25
|
authors | Huang, X., Turiso, F.Gonzalez-Lopez.de., Sun, D., Yosup, R., Bartberger, M.D., Beck, H.P., Cannon, J., Shaffer, P., Oliner, J.D., Olson, S.H., Medina, J.C. |
compound |
source |
symmetry | |
|
crystal cell |
length a |
length b |
length c |
angle alpha |
angle beta |
angle gamma |
|
|
|
|
|
|
|
method | X-Ray Diffraction | resolution | 2.30 |
ligand | 1MQ
| enzyme |
|
Gene Ontology |
Chain | Function | Process | Component | A |
|
|
|
|
Primary reference | Rational Design and Binding Mode Duality of MDM2-p53 Inhibitors., Gonzalez-Lopez de Turiso F, Sun D, Rew Y, Bartberger MD, Beck HP, Canon J, Chen A, Chow D, Correll TL, Huang X, Julian LD, Kayser F, Lo MC, Long AM, McMinn D, Oliner JD, Osgood T, Powers JP, Saiki AY, Schneider S, Shaffer P, Xiao SH, Yakowec P, Yan X, Ye Q, Yu D, Zhao X, Zhou J, Medina JC, Olson SH, J Med Chem. 2013 Apr 18. PMID:23597064 |